Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Ambros

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapyB H Kushner, N K Cheung, M P LaQuaglia, et al.
British Journal of Cancer|June 28, 2002
Prognostic impact of chromosomal aberrations in Ewing tumoursC M Hattinger, U Pötschger, M Tarkkanen, et al.
Medical and Pediatric Oncology|July 24, 2001
Prognostic significance of DNA di-tetraploidy in neuroblastomaR Ladenstein, I M Ambros, U Pötschger, et al.
Klinische Padiatrie|July 1, 1996
[Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study]R Ladenstein, P F Ambros, C Urban, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas]R Kerbl, C E Urban, R Ladenstein, et al.
British Journal of Cancer|September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupB De Bernardi, V Mosseri, H Rubie, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Survival from locally invasive or widespread neuroblastoma without cytotoxic therapyB H Kushner, N K Cheung, M P LaQuaglia, et al.
British Journal of Cancer|June 28, 2002
Prognostic impact of chromosomal aberrations in Ewing tumoursC M Hattinger, U Pötschger, M Tarkkanen, et al.
Medical and Pediatric Oncology|July 24, 2001
Prognostic significance of DNA di-tetraploidy in neuroblastomaR Ladenstein, I M Ambros, U Pötschger, et al.
Klinische Padiatrie|July 1, 1996
[Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study]R Ladenstein, P F Ambros, C Urban, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas]R Kerbl, C E Urban, R Ladenstein, et al.
British Journal of Cancer|September 4, 2008
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma GroupB De Bernardi, V Mosseri, H Rubie, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality assessment of genetic markers used for therapy stratificationI M Ambros, J Benard, M Boavida, et al.
Pageof 9